Endogenous opioids and oligodendroglial function: possible autocrine/paracrine effects on cell survival and development.
about
Systematic Review of Pharmacological Properties of the Oligodendrocyte LineageHIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinasesInteractive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neuronsPathobiology of dynorphins in trauma and disease.Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancyOpiate drug use and the pathophysiology of neuroAIDS.Cell-specific loss of kappa-opioid receptors in oligodendrocytes of the dysmyelinating jimpy mouse.HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology.Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure.Enhancing Remyelination through a Novel Opioid-Receptor Pathway.Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System.
P2860
Q26768210-331BD836-AC17-424F-AE59-5E9DE2B15518Q33647438-44EA28CB-D229-4CB9-A670-69696876C770Q33798722-7564AD87-B7A1-4664-AB48-715EADFF2FCEQ34086976-FA4AA234-03BF-44A3-9CB5-48B1941EFD98Q35007416-4C87AA63-CDAE-4B87-ABF8-92C9B1382C22Q35009483-D2CF19E5-19B6-4F71-BC44-1518788E70CBQ35014175-FFB38405-DB86-4FF4-9087-F0890569E704Q35122783-A36EACA0-C0FC-4BC7-8FEB-C973870333FCQ35552420-CE41AFCB-F3BC-4C72-A03C-F9DBCD878CF1Q36201412-8D8642FF-0569-4AC1-A3FD-70FFD6EE99BFQ39832543-4E8CA29D-3CCE-4D68-B674-721B625A6FE2Q41763649-2B491C00-681C-4A03-9666-5C02FCE1D28BQ42073149-3F4AED36-2DC2-4DC8-B9ED-E1D153A24771Q42362928-CA447821-E0B5-41AD-BC3B-842828AE800DQ49270407-67C3EE7E-5698-4DC9-8A19-2A6D740757F9
P2860
Endogenous opioids and oligodendroglial function: possible autocrine/paracrine effects on cell survival and development.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Endogenous opioids and oligode ...... cell survival and development.
@en
Endogenous opioids and oligode ...... cell survival and development.
@nl
type
label
Endogenous opioids and oligode ...... cell survival and development.
@en
Endogenous opioids and oligode ...... cell survival and development.
@nl
prefLabel
Endogenous opioids and oligode ...... cell survival and development.
@en
Endogenous opioids and oligode ...... cell survival and development.
@nl
P2093
P2860
P356
P1433
P1476
Endogenous opioids and oligode ...... cell survival and development.
@en
P2093
P2860
P304
P356
10.1002/GLIA.1080
P577
2001-08-01T00:00:00Z